Medicinal Research Reviews

Medicinal Research Reviews英文簡(jiǎn)介

Medicinal Research Reviews publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions.

Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs.

Articles are mainly solicited by the Editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline (see below) before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

Medicinal Research Reviews中文簡(jiǎn)介

《Medicinal Research Reviews》是一本由WILEY出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于1981年，刊期Bimonthly，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCI、SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 1區(qū)，小類學(xué)科：藥物化學(xué) 1區(qū)；藥學(xué) 1區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q1。該刊發(fā)文范圍涵蓋藥物化學(xué)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外藥物化學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為12.388，平均審稿速度約稿?周期不定。

中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	1區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	1區(qū) 1區(qū)	是	是

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q1	PHARMACOLOGY & PHARMACY	Q1	12.388
	CHEMISTRY, MEDICINAL	Q1

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
12.388	119	15.30%	9.72%	未開放	約稿?周期不定

IF值(影響因子)趨勢(shì)圖